HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CZ0775

inhibits MEK1 and MEK2; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Pyridones: 14
      - CZ0775: 1
Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - CZ0775: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - CZ0775: 1

Experts

1.	Cho, Suk Young: 1 article (12/2013)
2.	Choi, Jene: 1 article (12/2013)
3.	Hwang, Jung Jin: 1 article (12/2013)
4.	Jang, Se Jin: 1 article (12/2013)
5.	Kim, Choung-Soo: 1 article (12/2013)
6.	Lee, Gilnam: 1 article (12/2013)
7.	Lee, Je-Hwan: 1 article (12/2013)
8.	Lee, Sang-wook: 1 article (12/2013)
9.	Lim, Chulsoo: 1 article (12/2013)
10.	Seo, Jeongbeob: 1 article (12/2013)

Related Diseases

1.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/01/2013 - "Here, we identified a novel MEK1/2 inhibitor, CZ0775, and compared its cytotoxic effects to those of AZD6244 (selumetinib) in non-small cell lung cancer (NSCLC) cell lines harboring EGFR mutations. "

Related Drugs and Biologics

1.	AZD 6244